
    
      Cohort 1:

      The purpose of this single arm study is to continue to assess safety and performance of the
      CVI Paclitaxel-Coated PTA Balloon Catheter in the treatment of de novo or restenotic lesions
      in the superficial femoral (SFA) and/or popliteal arteries.

      Cohort 2:

      A second cohort is being added to evaluate this patient population for treatment of in-stent
      restenotic lesions.

      Cohort 1:

      Prospective, multi-center, single-arm study.

      Cohort 2:

      Prospective, multi-center, single-arm study compared to a historical control patients.

      Cohort 1:

      Follow-up assessments will occur at discharge, 1 month, 6 months, 12 months, 24 months,36
      months, 48 months, and 60 months following the study procedure.

      Cohort 2:

      Follow-up assessments will occur at discharge, 1 month, 6 months, 12 months, 24 months and 36
      months following the study procedure.
    
  